{
    "nct_id": "NCT04779554",
    "official_title": "A Randomized Phase 2 Trial of Flat Dose Vs. Weight-based Dose of Intra-peritoneal (IP) Chemotherapy for Patients Undergoing Cytoreductive Surgery and Heated Intra-peritoneal Chemotherapy (CRS/HIPEC) for Advanced Gastrointestinal Malignancy",
    "inclusion_criteria": "* Patients diagnosed with one of the following: low-grade appendiceal mucinous neoplasm, appendiceal cancer with peritoneal carcinomatosis, colorectal cancer with peritoneal carcinomatosis\n* ECOG performance status < 3\n* Candidate for grossly complete cytoreductive surgery\n* Life expectancy greater than 3 months\n* Adequate organ and marrow function\n* Ability to understand and the willingness to sign a written informed consent document\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Any extra-abdominal metastases\n* Untreated lung metastases\n* Liver metastases not amenable to resection or ablation\n* Known brain metastases\n* Chemotherapy or radiotherapy within 4 weeks prior to entering the study\n* Presence of residual significant adverse events attributed to prior cancer treatment\n* Currently receiving any other investigational therapeutic agents\n* History of allergic reactions attributed to compounds of similar chemical or biologic composition to Mitomycin C.\n* Pregnant or breast-feeding women\n* Uncontrolled ongoing illness",
    "miscellaneous_criteria": ""
}